Scholarly Journals--Published

  • Kim E, Williams A, Chang J, Butala N, Firek M. Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety. Ment Health Clin. 2023 Dec 1;13(6):311-316. doi: 10.9740/mhc.2023.12.311. PMID: 38058597; PMCID: PMC10696170. (12/2023)
  • Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. J Child Adolesc Psychopharmacol. 2023 Dec;33(10):433-438. doi: 10.1089/cap.2023.0049. Epub 2023 Nov 1. PMID: 37910863. (12/2023)
  • Hamad MA, Williams A, Kneebusch J, Butala N. Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital. Ment Health Clin. 2023 Oct 2;13(5):233-238. doi: 10.9740/mhc.2023.10.233. PMID: 38131054; PMCID: PMC10732127. (10/2023)
  • Kang C, Williams A, Butala N. Prescribing Practices for Agitation Medication in Obese Patients Admitted to the Emergency Department. J Psychiatr Pract. 2023 Sep 1;29(5):359-366. doi: 10.1097/PRA.0000000000000734. PMID: 37678365. (09/2023)
  • Stutzman DL, Leiby LE, Temelie A, Maroney M, Williams AM, et al. Role of Board-Certified Psychiatric Pharmacists in childand adolescent psychiatry.J Am Coll Clin Pharm. 2023;1-11.doi:10.1002/jac5.1880STUTZMANET AL.11 (07/2023) (link)
  • Haight RJ, Di Polito CN, Payne GH, Bostwick JR, Fulbright A, Lister JF, Williams AM. Psychotropic stewardship: Advancing patient care. Ment Health Clin. 2023 Apr 12;13(2):36-48. doi: 10.9740/mhc.2023.04.036. PMID: 37063939; PMCID: PMC10094994. (04/2023)
  • Dopheide JA, Werremeyer A, Haight RJ, Gutierrez CA, Williams AM. Positioning psychiatric pharmacists to improve mental health care. Ment Health Clin. 2022 Apr 14;12(2):77-85. doi: 10.9740/mhc.2022.04.077. PMID: 35582321; PMCID: PMC9009818. (04/2022)
  • Butala N, Williams A, Kneebusch J, Mitchell M. Impact of a pharmacist-driven tardive dyskinesia screening service. Ment Health Clin. 2021 Jul 16;11(4):248-253. doi: 10.9740/mhc.2021.07.248. PMID: 34316421; PMCID: PMC8287863. (07/2021)
  • Snyder SD, Williams A, Mitchell M, Kneebusch J. Use of Intramuscular Chlorpromazine Versus Intramuscular Olanzapine for the Management of Acute Agitation and Aggression in Youth. J Pediatr Pharmacol Ther. 2021;26(1):33-41. doi: 10.5863/1551-6776-26.1.33. Epub 2021 Jan 4. PMID: 33424498; PMCID: PMC7792138. (01/2021)
  • Williams AM. Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness. Ment Health Clin. 2018 Aug 30;8(5):208-213. doi: 10.9740/mhc.2018.09.208. PMID: 30206503; PMCID: PMC6125121. (08/2018)
  • Williams, A. M., & Knox, E. D. (2017). When to prescribe antidepressants to treat comorbid depression and pain disorders. Current Psychiatry16(1), 55-58. (01/2017) (link)
  • Wasylyshen A, Williams AM. Second-generation antipsychotic use in borderline personality disorder: What are we targeting? Ment Health Clin. 2016 Mar 8;6(2):82-88. doi: 10.9740/mhc.2016.03.82. PMID: 29955452; PMCID: PMC6007581. (03/2016)
  • Williams AM, Park SH. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs. 2015 Feb;29(2):101-11. doi: 10.1007/s40263-014-0222-y. PMID: 25537107. (02/2015) (link)
  • Williams AM, Dopheide JA. Nonpsychiatric medication interventions initiated by a postgraduate year 2 psychiatric pharmacy resident in a patient-centered medical home. Prim Care Companion CNS Disord. 2014 Nov 6;16(6):10.4088/PCC.14m01680. doi: 10.4088/PCC.14m01680. PMID: 25834765; PMCID: PMC4374824. (11/2014)